{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:50:09Z","timestamp":1785333009509,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/04177-4"],"award-info":[{"award-number":["2023\/04177-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vph.2025.107523","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T15:39:02Z","timestamp":1752853142000},"page":"107523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Antagonism of the complement receptor reduces oxidative stress and matrix metalloproteinase (MMP)-2 activity in the aortas of mice with angiotensin-II-induced hypertension"],"prefix":"10.1016","volume":"160","author":[{"given":"Luan Victor Resque","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela M.","family":"Blascke de Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Marcel Silva","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Teles","family":"de Oliveira Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evellin Karina Pires","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos Farias Alves","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Tostes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2025.107523_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20130407","article-title":"Immune mechanisms in hypertension and vascular injury","volume":"126","author":"Schiffrin","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.vph.2025.107523_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-016-0628-7","article-title":"Role of inflammation and immunity in hypertension: recent epidemiological, laboratory, and clinical evidence","volume":"18","author":"Caillon","year":"2016","journal-title":"Curr. Hypert. Rep."},{"key":"10.1016\/j.vph.2025.107523_bb0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.vph.2025.107523_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2025.107523_bb0025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nri3761","article-title":"Complement-tapping into new sites and effector systems","volume":"14","author":"Kolev","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vph.2025.107523_bb0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1084\/jem.20121525","article-title":"Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells","volume":"210","author":"Kwan","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vph.2025.107523_bb0035","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/CIRCRESAHA.117.312153","article-title":"Deficiency of complement C3a and C5a receptors prevents angiotensin II-induced hypertension via regulatory T cells","volume":"122","author":"Chen","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107523_bb0040","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/ajh.2011.214","article-title":"Role of complement 3a in the synthetic phenotype and angiotensin II-production in vascular smooth muscle cells from spontaneously hypertensive rats","volume":"25","author":"Han","year":"2012","journal-title":"Am. J. Hypert."},{"key":"10.1016\/j.vph.2025.107523_bb0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.yjmcc.2009.09.018","article-title":"Extracellular matrix alterations in hypertensive vascular remodeling","volume":"48","author":"Lemari\u00e9","year":"2010","journal-title":"J. Mol. Cel. Cardiol."},{"key":"10.1016\/j.vph.2025.107523_bb0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000441621","article-title":"Matrix metaloproteinase 2 as potential mediator of vascular smooth muscle cell migration and chronic vascular remodeling in hypertension","volume":"52","author":"Belo","year":"2016","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.vph.2025.107523_bb0055","article-title":"Type I collagen proteolysis by matrix metaloproteinase-2 contributes to focal adhesion kinase activation and vascular smooth muscle cell proliferation in the aorta in early hypertension","volume":"152","author":"Neves","year":"2023","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.vph.2025.107523_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vph.2018.10.002","article-title":"Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension","volume":"116","author":"Blascke de Mello","year":"2018","journal-title":"Vascul. Pharmacol."},{"issue":"983","key":"10.1016\/j.vph.2025.107523_bb0065","article-title":"Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metaloproteinase-2 contributes to vascular dysfunction in early hypertension","volume":"15","author":"Blascke de Mello","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2025.107523_bb0070","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1089\/ars.2008.2393","article-title":"Role of NFkB in flow-induced vascular remodeling","volume":"11","author":"Castier","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.vph.2025.107523_bb0075","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1476-5381.2011.01360.x","article-title":"Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension","volume":"164","author":"Cau","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2025.107523_bb0080","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.4049\/jimmunol.1601386","article-title":"The complement C3a-C3aR axis promotes development of thoracic aortic dissection via regulation of MMP2 expression","volume":"200","author":"Ren","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2025.107523_bb0085","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/cvr\/cvx115","article-title":"Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury","volume":"113","author":"Barhoumi","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2025.107523_bb0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2007.10.011","article-title":"Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats","volume":"198","author":"Castro","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2025.107523_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-4482-9_1","article-title":"In situ zymography and localization of bright green fluorescent gelatinase activity in tissue sections","volume":"2918","author":"Castro","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.vph.2025.107523_bb0100","first-page":"598","article-title":"Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging","volume":"35","author":"Propson","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2025.107523_bb0105","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/ATVBAHA.114.304927","article-title":"Complement-mediated macrophage polarization in perivascular adipose tissue contributes to vascular injury in deoxycorticosterone acetate\u2013salt mice","volume":"35","author":"Ruan","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2025.107523_bb0110","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1124\/jpet.114.218123","article-title":"Differential effects of complement activation products C3a and C5a on cardiovascular function in hypertensive pregnant rats","volume":"351","author":"Lillegard","year":"2014","journal-title":"J. Phamacol. Exp. Ther."},{"key":"10.1016\/j.vph.2025.107523_bb0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.freeradbiomed.2014.07.003","article-title":"Complement-dependent NADPH oxidase enzyme activation in renal ischemia\/reperfusion injury","volume":"74","author":"Simone","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2025.107523_bb0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5607\/en.2019.28.2.216","article-title":"C3a receptor inhibition protects brain endothelial cells against oxygen-glucose deprivation\/ reperfusion","volume":"28","author":"Ahmad","year":"2019","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.vph.2025.107523_bb0125","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/01.HYP.0000154680.44184.01","article-title":"Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition","volume":"45","author":"Bouvet","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2025.107523_bb0130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1476-5381.2011.01583.x","article-title":"Inhibition of matrix metalloproteinase-2 improves endothelial function and prevents hypertension in insulin-resistant rats","volume":"165","author":"Nagareddy","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2025.107523_bb0135","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.freeradbiomed.2009.02.011","article-title":"Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension","volume":"46","author":"Castro","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2025.107523_bb0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.atherosclerosis.2018.01.031","article-title":"Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension","volume":"270","author":"Pereira","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2025.107523_bb0145","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2025.107523_bb0150","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/ATVBAHA.113.303120","article-title":"Complement 5a receptor mediates angiotensin II\u2013induced cardiac inflammation and remodeling","volume":"34","author":"Zhang","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912500062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912500062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:15:41Z","timestamp":1763644541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153718912500062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"alternative-id":["S153718912500062X"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2025.107523","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antagonism of the complement receptor reduces oxidative stress and matrix metalloproteinase (MMP)-2 activity in the aortas of mice with angiotensin-II-induced hypertension","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2025.107523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107523"}}